MNK News 83.19 10/17/2014 05:21:17 Mallinckrodt Plc Ordinary

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mallinckrodt Plc Ordinary Share (MNK) 83.19 $MNK

Supernus' Trokendi XR Faces Generic Threat from Zydus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 5:45PM CDT
Supernus Pharmaceuticals, Inc. (SUPN) received a Paragraph IV notice from Zydus which is looking to get its generic version of Supernus' Trokendi XR approved in the U.S.
MNK: 83.19 (-1.14), ACT: 222.07 (+4.83), SUPN: 8.39 (+0.23), MYL: 48.77 (+1.39)

Mallinckrodt Gives FY15 Guidance Post Questcor Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 4:10PM CDT
Mallinckrodt plc (MNK) has issued its financial guidance for the fiscal year ending Sep 25, 2015 following the completion of the Questcor acquisition.
MNK: 83.19 (-1.14), ACT: 222.07 (+4.83), LGND: 48.86 (+2.58), MYL: 48.77 (+1.39)

Mallinckrodt expects fiscal 2015 adjusted EPS in the USD6.70 to USD7.20 range
M2 - Wed Oct 15, 6:05AM CDT
Biopharmaceutical company Mallinckrodt (NYSE:MNK) said on Tuesday that it expects its adjusted diluted earnings per share (EPS) in the USD6.70 to USD7.20 range for fiscal year ending 25 September 2015.
MNK: 83.19 (-1.14)

Mallinckrodt shares rise on earnings outlook
AP - Tue Oct 14, 9:07AM CDT
NEW YORK (AP) — Shares of Mallinckrodt PLC rose Tuesday after the health care products maker posted an earnings outlook for next year that beat Wall Street expectations.
MNK: 83.19 (-1.14), QCOR: 93.60 (+1.52)

Mallinckrodt plc Provides Fiscal Year 2015 Financial Guidance
Business Wire - Tue Oct 14, 6:00AM CDT
Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced financial guidance for its fiscal year ending September 25, 2015.
MNK: 83.19 (-1.14)

Trade-Ideas: Mallinckrodt (MNK) Is Today's "Water-Logged And Getting Wetter" Stock
at The Street - Mon Oct 13, 9:59AM CDT
Trade-Ideas LLC identified Mallinckrodt (MNK) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
MNK: 83.19 (-1.14)

10 Stocks Billionaire John Paulson Loves in 2014
at The Street - Mon Oct 13, 9:04AM CDT
Here's a look at 10 stocks that Paulson & Co. bought in the most recently reported quarter.
MNK: 83.19 (-1.14), AGN: 178.00 (+0.41), QCOR: 93.60 (+1.52), HSH: 62.96 (unch), SHPG: 178.46 (+7.97), COV: 85.50 (-0.36), DTV: 83.88 (+0.25), DG: 58.77 (+0.09), FDO: 76.37 (-0.16), CIE: 10.61 (+0.48)

AxoGen (AXGN) Shows Strength: Stock Up 15.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 8:39AM CDT
AxoGen, Inc. (AXGN) was a big mover last session, as its shares rose over 15% on the day.
MNK: 83.19 (-1.14), ACT: 222.07 (+4.83), AXGN: 2.66 (-0.25), MYL: 48.77 (+1.39)

'Mad Money' Lightning Round: Buy Kimberly-Clark or Procter & Gamble
at The Street - Sat Oct 11, 5:00AM CDT
Cramer says FMC and Expedia are not done going lower and thinks of Organovo Holdings as a speculative stock.
MNK: 83.19 (-1.14), ONVO: 6.21 (+0.04), KMB: 105.04 (-0.37), EXPE: 75.08 (+0.98), FMC: 56.14 (+1.83), PG: 82.24 (-0.71)

Jim Cramer's Top Stock Picks: ISIS KMB PG MNK
at The Street - Sat Oct 11, 5:00AM CDT
Cramer sees better times ahead for Isis Pharmaceuticals and is a big fan of Kimberly-Clark.
MNK: 83.19 (-1.14), ISIS: 40.56 (+1.59), KMB: 105.04 (-0.37), PG: 82.24 (-0.71)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Oct 10, 6:59PM CDT
From JPMorgan to General Electric, Cramer says he'll be all over earnings next week.
MNK: 83.19 (-1.14), GE: 24.25 (-0.03), HON: 86.39 (+1.28), C: 49.75 (+0.07), KMB: 105.04 (-0.37), MCHP: 39.19 (+1.46), FMC: 56.14 (+1.83), WFC: 48.13 (+0.28), CSX: 32.98 (unch), INTC: 30.85 (-0.42), NFLX: 361.70 (-86.89), ISIS: 40.56 (+1.59), JPM: 55.08 (-0.45), ONVO: 6.21 (+0.04), EXPE: 75.08 (+0.98), PG: 82.24 (-0.71), PPG: 181.83 (+1.33)

Impax Up, Set to Buy Tower Holdings & Lineage Therapeutics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 4:05PM CDT
Impax Laboratories Inc.'s (IPXL) signed a definitive agreement to acquire privately held Tower Holding and Lineage Therapeutics.
MNK: 83.19 (-1.14), IPXL: 27.00 (+0.26), ACT: 222.07 (+4.83), MYL: 48.77 (+1.39)

Impax Laboratories Inc. (IPXL) in Focus: Stock Rises 11.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:32AM CDT
Impax Laboratories Inc. (IPXL) was a big mover last session, as the company saw its shares rise nearly 12% on the day.
MNK: 83.19 (-1.14), ACT: 222.07 (+4.83), MYL: 48.77 (+1.39)

Teva Starts Rolling Submission of its Pain Drug CEP-33237 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 3:45PM CDT
Teva Pharmaceutical (TEVA) started a rolling submission of the NDA in the U.S. for CEP-33237.
MNK: 83.19 (-1.14), ACT: 222.07 (+4.83), MYL: 48.77 (+1.39), TEVA: 51.56 (+1.47)

Ligand Provides Better-than-Expected Q3 Earnings Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 3:10PM CDT
Ligand Pharmaceuticals Incorporated (LGND) is expecting its third quarter 2014 adjusted earnings per share to be between 33 and 37 cents per share.
MNK: 83.19 (-1.14), ACT: 222.07 (+4.83), LGND: 48.86 (+2.58), MYL: 48.77 (+1.39)

Teva to Concentrate on Core Specialty Therapeutics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 5:09PM CDT
Teva Pharmaceutical (TEVA) announced that it will be primarily focusing on its core therapeutic areas.
MNK: 83.19 (-1.14), ACT: 222.07 (+4.83), TEVA: 51.56 (+1.47), GSK: 42.88 (-0.25)

Actavis in Acquisition Mode, Durata Deal to Boost Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 4:42PM CDT
Actavis (ACT) will expand its infectious disease portfolio through the Durata (DRTX) acquisition.
DRTX: 23.60 (-0.03), MNK: 83.19 (-1.14), ACT: 222.07 (+4.83), SUPN: 8.39 (+0.23)

Eli Lilly Stops Developing Tabalumab Due to Efficacy Issues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 4:30PM CDT
Eli Lilly and Company (LLY) will discontinue tabalumab's development due to insufficient efficacy results in the phase III ILLUMINATE program.
MNK: 83.19 (-1.14), ACT: 222.07 (+4.83), LGND: 48.86 (+2.58), LLY: 61.90 (-0.97)

AbbVie's Humira Label Expanded in U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 4:05PM CDT
AbbVie Inc.'s (ABBV) Humira gained FDA approval for moderately-to-severely active polyarticular juvenile idiopathic arthritis in patients aged less than or equal to 2 years.
MNK: 83.19 (-1.14), ACT: 222.07 (+4.83), LGND: 48.86 (+2.58), ABBV: 52.90 (-1.73)

Progenics Gets $40M Milestone on FDA Approval of Relistor - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 4:05PM CDT
Progenics Pharmaceuticals, Inc. (PGNX) received a $40 million milestone payment from Salix Pharmaceuticals, Inc. (SLXP) on the U.S. approval of Relistor.
MNK: 83.19 (-1.14), PGNX: 4.85 (+0.21), ACT: 222.07 (+4.83), SLXP: 137.38 (+4.96)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 105

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading
Auria, LSAS Team Up: Japan Space Frontier Beckons

Updated Category News Views 105

Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 5

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 174

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
Mantle's Japan Listing Puts $MNT Through a Real Test

Updated Category News Views 47

Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...

Continue Reading
Cavalry’s I-70 Towing Bet Starts With Columbus Base

Updated Category News Views 71

A jackknifed tractor-trailer does not care about a private-equity playbook. It needs the right rig, a trained crew and somebody arriving before a blocked highway turns into an all-day mess. That unglamorous reality is exactly why Southfield Capital’s new Cavalry Fleet Services platform deserves a closer look. Commercial towing is a necessary, hard-edged local business...

Continue Reading
ISDN Holdings: Leading APAC Automation with Innovation

Updated Category News Views 81

Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...

Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 138

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 157

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
Workday GO for Financials Targets the Messy Middle

Updated Category News Views 25

Spreadsheets rarely die gracefully; they get buried under approvals, reconciliations, and the frantic scavenger hunt before an audit. Workday is aiming straight at that unpleasant moment with Workday GO for Financials, announced November 18 at Workday Rising EMEA in Barcelona. The pitch is not terribly romantic, thank goodness. It is a simpler way for growing companies to...

Continue Reading

Top 5 Most Recently Viewed Articles

Kering Faces Challenges as Goldman Sachs Downgrades Rating

Updated Category News Views 108

Kering's stock price took a serious hit back in early 2024 after Goldman Sachs slapped a "sell" rating on the luxury group's shares. At the time, they were sitting at €249.50, reflecting a sharp decline of about 2.9%. Desks were buzzing over this downgrade, particularly because it pointed fingers at Gucci—a brand that's been Kering’s cash cow for years. Kering's...

Continue Reading
Treatment.com AI to Showcase Innovations at Cantech Conference

Updated Category News Views 174

Treatment.com AI, a player in healthcare tech, geared up for its big moment at the Cantech Letter Investment Conference back in 2024. The spotlight was on Dr. Essam Hamza, CEO of the firm, who was set to reveal how their advanced AI-driven solutions were set to transform patient care. You could almost hear traders buzzing about the potential impact on share prices as the...

Continue Reading
Bombardier Celebrates First Challenger 3500 Deliveries

Updated Category News Views 408

Landmark Deliveries of the Challenger 3500 Bombardier proudly announces a significant achievement with the beginning of deliveries of three state-of-the-art Challenger 3500 aircraft to Aloula Aviation. This event marks a milestone as these are the first Challenger 3500 aircraft registered in Saudi Arabia, showcasing Bombardier's dedication to enhancing global aviation....

Continue Reading
Siili Solutions Shares Repurchase Update for 2025

Updated Category News Views 167

Overview of Siili Solutions Plc's Share Repurchase Siili Solutions Plc is taking significant steps to enhance shareholder value through strategic share buybacks. Recently, they announced a share repurchase on June 26, 2025, which adds to their ongoing efforts in the market. This initiative is an essential part of their financial strategy, showing a commitment to returning...

Continue Reading
Xiaomi's YU7 SUV Surpasses Tesla Model Y in China Sales

Updated Category News Views 236

Xiaomi's YU7 SUV Emerges as a Strong Contender Xiaomi Corp. has made a significant impact in the electric vehicle sector, particularly in January when their YU7 SUV surpassed Tesla Inc.'s Model Y in sales within the Chinese market. The impressive sales figures highlight Xiaomi's growing influence in the automotive landscape. Strong Sales Performance of the YU7 During the...

Continue Reading